Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
17,580,872
-
Share change
-
+3,612,330
-
Total reported value
-
$161,369,763
-
Put/Call ratio
-
336%
-
Price per share
-
$9.18
-
Number of holders
-
90
-
Value change
-
+$32,956,071
-
Number of buys
-
45
-
Number of sells
-
42
Institutional Holders of INOVIO PHARMACEUTICALS INC - COM NEW (INO) as of Q4 2014
As of 31 Dec 2014,
INOVIO PHARMACEUTICALS INC - COM NEW (INO) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,580,872 shares.
The largest 10 holders included
State Street Corp, BlackRock Fund Advisors, VANGUARD GROUP INC, WASATCH ADVISORS INC, BlackRock Institutional Trust Company, N.A., PUTNAM INVESTMENTS LLC, NORTHERN TRUST CORP, MORGAN STANLEY, Catalyst Capital Advisors LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
90
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.